Stock Performance

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Upcoming & Recent Events

IR PR Contacts

Investor Contact:
Meredith Kaya
(617) 599-8178
Email: meredith.kaya@apellis.com

Media Relations:
Lissa Pavluk
(617) 977-6764
Email: media@apellis.com

Receive Email Alerts

Sign up to receive email alerts whenever Apellis Pharmaceuticals, Inc. posts new information to the site. Just enter your email address and click Submit.